Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: A double-blind, placebo-controlled study of quinapril
- 15 November 1993
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 22 (6), 1557-1563
- https://doi.org/10.1016/0735-1097(93)90578-o
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Comparative properties of angiotensin-converting enzyme inhibitors: Relations with inhibition of tissue angiotensin-converting enzyme and potential clinical implicationsThe American Journal of Cardiology, 1992
- Comparative pharmacokinetics of captopril, enalapril, and quinaprilThe American Journal of Cardiology, 1992
- The Effects of ACE Inhibitors on Exercise Capacity in the Treatment of Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1990
- Effects of physical training in chronic heart failureThe Lancet, 1990
- Preliminary Hemodynamic Report of the Efficacy and Safety of Quinapril in Acute and Chronic Treatment of Patients with Congestive Heart FailureAngiology, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987
- Placebo-Controlled Study of Lisinopril in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1987
- Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failureJournal of the American College of Cardiology, 1985
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Hemodynamic and hormonal responses during captopril therapy for heart failure: Acute, chronic and withdrawal studiesThe American Journal of Cardiology, 1982